Synthomer Shares Surge as Refinancing Fears Subside

Synthomer shares surge over 20% after management rules out equity dilution, highlighting strong pricing power, margin expansion, and a clear debt reduction plan.

Investors in Synthomer breathed a collective sigh of relief last week, propelling the specialty chemicals group’s stock to a dramatic single-day gain. The catalyst was a clear signal from management that a heavily speculated equity dilution is off the table, shifting the focus squarely to internal debt reduction and operational resilience.

On Friday, Synthomer’s share price jumped more than 20 percent, closing at 36.00 GBX. This powerful rally appears to mark an end to a prolonged period of extreme volatility, restoring market confidence in the company’s ability to navigate a challenging geopolitical landscape and strengthen its balance sheet through its own initiatives.

Operational Strength and Strategic Shift

A key factor behind the improving outlook is Synthomer’s demonstrated pricing power. The company has successfully passed increased raw material and energy costs on to its customers. Even amid military tensions in Iran and associated price inflation, Synthomer defended its margins in core segments. Global supply chains remained robust, and production in the Middle East continued without major disruption.

The market is viewing the evolution of the gross margin particularly favorably. A strategic pivot away from commoditized latex business toward higher-value specialty solutions for adhesives and coatings has driven a margin expansion of over 400 basis points during the past three years. A diversified regional footprint has been instrumental in this improvement.

Solid Financial Footing and Debt Focus

Financially, the group stands on firmer ground than many market participants had anticipated. For the 2025 fiscal year, management confirmed revenue of approximately £1.74 billion. Adjusted EBITDA is projected to land between £135 million and £138 million. Internal cost-saving programs have helped to cushion the impact of weaker demand from the construction industry.

Key Financial Metrics:
- Liquidity: £385 million in available cash and undrawn credit facilities.
- Leverage: The ratio of net debt to EBITDA sits between 4.7x and 4.8x.
- Cash Flow: The full year 2025 concluded with a positive free cash flow position.

This level of indebtedness remains within the bank covenant limit of 5.25x. Management’s current priority is to finalize negotiations for the refinancing of loans maturing in 2027 and to advance its divestment program.

The start to the new 2026 year is reported to be in line with plans. Operational momentum is building, despite the ongoing complexity of the macroeconomic environment. Investors will gain final clarity on the company’s financial health in late April 2026, when the audited full-year results are published. The slight delay in publication is intended to allow the refinancing process to be completed in parallel with the audit.